SPONSOR
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Pancreatic CancerMetastatic Prostate CancerHead and Neck CancerSquamous Cell CarcinomaOral Cavity CancerOropharyngeal CancerLaryngeal CancerSinonasal Squamous Cell CarcinomaHPV (Human Papillomavirus)-Associated CarcinomaSkull Base Tumors
NCT06941857 Phase 2
Recruiting
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Pancreatic Cancer
NCT06826924
Recruiting
7-Days Water-Only Fasting Trial in Prostate Cancer
Metastatic Prostate Cancer
NCT07209189 Phase 2
Recruiting
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Head and Neck Cancer
NCT06796543
Recruiting
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Metastatic Sarcoma
NCT06059118 Phase 2
Recruiting
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer